Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
Gary R. Lichtenstein(University of Pennsylvania), William J. Sandborn(University of San Diego)
Cited by 906
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Crohn's disease
|The Lancet|2012|2.1k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis
|Inflammatory Bowel Diseases|2008|950
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
|New England Journal of Medicine|2012|794